Heart failure in a multiethnic population in Kuala Lumpur, Malaysia

European Journal of Heart Failure

Volumn 5, Issue 4, 2003, Pages 569-574

  Chong, Aun Yeong ^a   Rajaratnam, Ratna ^a   Hussein, Nur Run ^a   Lip, Gregory Y H ^a  

^a UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

Author keywords

Heart failure; Malaysia; Management

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CAUCASIAN; CLINICAL FEATURE; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; DIABETES MELLITUS; ETHNIC DIFFERENCE; FEMALE; HEART FAILURE; HUMAN; HYPERTENSION; INDIAN; MAJOR CLINICAL STUDY; MALAYSIA; MALE; PREVALENCE; PRIORITY JOURNAL; RACE DIFFERENCE;

AGED; AGED, 80 AND OVER; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; CORONARY DISEASE; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALAYSIA; MALE; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES;

EID: 0041967446     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1388-9842(03)00013-8     Document Type: Article

References (31)

1. Gibbs CR, Lip GYH. Ethnicity and heart failure. Eur Heart J 1999;20(19):1436-7.
2. Martin TC. M-mode echocardiographic findings in a contemporary Afro-Caribbean population referred for evaluation of congestive cardiac failure. West Indian Med J 2002;51(2):93-6.
3. Carson P, Ziesche S, Johnson G, Cohn JN. Racial differences in response to therapy for heart failure: analysis of the vasodilator-heart failure trials. Vasodilator-Heart Failure Trial Study Group. J Card Fail 1999;5(3):178-87.
4. Lane D, Beevers DG, Lip GYH. Ethnic differences in blood pressure and the prevalence of hypertension in England. J Hum Hypertens 2002;16(4):267-73.
5. Mustaffa BE. Diabetes mellitus in peninsular Malaysia: ethnic differences in prevalence and complications. Ann Acad Med Singapore 1985;14(2):272-6.
6. Lip GYH, Zarifis J, Beevers DG. Acute admissions with heart failure to a district general hospital serving a multiracial population. Int J Clin Pract 1997;51(4):223-7.
7. Alexander M, Grumbach K, Remy L, Rowell R, Massie BM. Congestive heart failure hospitalizations and survival in California: patterns according to race/ethnicity. Am Heart J 1999;137(5):919-27.
8. Aronow WS, Ahn C, Kronzon I. Comparison of incidences of congestive heart failure in older African-Americans, Hispanics, and whites. Am J Cardiol 1999;84(5):611-612, A9.
9. Demirovic J, Prineas R, Rudolph M. Epidemiology of congestive heart failure in three ethnic groups. Congest Heart Fail 2001;7(2):93-6.
10. Dries DL, Exner DV, Gersh BJ, Cooper HA, Carson PE, Domanski MJ. Racial differences in the outcome of left ventricular dysfunction. N Engl J Med 1999;1340(8):609-16.
11. McDermott MM, Feinglass J, Lee P, et al. Heart failure between 1986 and 1994: temporal trends in drug-prescribing practices, hospital readmissions, and survival at an academic medical center. Am Heart J 1997;134(5 Pt 1):901-9.
12. Barron HV, Michaels AD, Maynard C, Every NR. Use of angiotensin-converting enzyme inhibitors at discharge in patients with acute myocardial infarction in the United States: data from the National Registry of Myocardial Infarction 2. J Am Coll Cardiol 1998;32(2):360-7.
13. Bungard TJ, McAlister FA, Johnson JA, Tsuyuki RT. Underutilisation of ACE inhibitors in patients with congestive heart failure. Drugs 2001;61(14):2021-33.
14. Pulignano G, Del Sindaco D, Tavazzi L, et al. Clinical features and outcomes of elderly outpatients with heart failure followed up in hospital cardiology units: data from a large nationwide cardiology database (IN-CHF Registry). Am Heart J 2002;143(1):45-55.
15. Philbin EF. Factors determining angiotensin-converting enzyme inhibitor underutilization in heart failure in a community setting. Clin Cardiol 1998;21(2):103-8.
16. Navis G, Faber HJ, de Zeeuw D, de Jong PE. ACE inhibitors and the kidney. A risk-benefit assessment. Drug Saf 1996;15(3):200-11.
17. Remme WJ, Swedberg K. Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J 2001;22(17):1527-60.
18. Dries DL, Exner DV, Domanski MJ, Greenberg B, Stevenson LW. The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction. J Am Coll Cardiol 2000;35(3):681-9.
19. Woo KS, Nicholls MG. High prevalence of persistent cough with angiotensin converting enzyme inhibitors in Chinese. Br J Clin Pharmacol 1995;40(2):141-4.
20. Ding PY, Hu OY, Pool PE, Liao W. Does Chinese ethnicity affect the pharmacokinetics and pharmacodynamics of angiotensin-converting enzyme inhibitors? J Hum Hypertens 2000;14(3):163-70.
21. Carson P, Ziesche S, Johnson G, Cohn JN. Racial differences in response to therapy for heart failure: analysis of the vasodilator-heart failure trials. Vasodilator-Heart Failure Trial Study Group. J Card Fail 1999;5(3):178-87.
22. Exner DV, Dries DL, Domanski MJ, Cohn JN. Lesser response to angiotensin-converting-enzyme inhibitor therapy in black as compared with white patients with left ventricular dysfunction. N Engl J Med 2001;344(18):1351-7.
23. Yancy CW, Fowler MB, Colucci WS, et al. Race and the response to adrenergic blockade with carvedilol in patients with chronic heart failure. N Engl J Med 2001;344(18):1358-65.
24. Sanderson JE, Young RP, Yu CM, Chan S, Critchley JA, Woo KS. Lack of association between insertion/deletion polymorphism of the angiotensin-converting enzyme gene and end-stage heart failure due to ischemic or idiopathic dilate cardiomyopathy in the Chinese. Am J Cardiol 1996;77(11):1008-10.
25. Zhou HH, Koshakji RP, Silberstein DJ, Wilkinson GR, Wood AJ. Altered sensitivity to and clearance of propanolol in men of Chinese descent as compared with American whites. N Engl J Med 1989;320(9):565-70.
26. Zhou HH, Adedoyin A, Wilkinson GR. Differences in plasma binding of drugs between Caucasians and Chinese subjects. Clin Pharmacol Ther 1990;48(1):10-7.
27. Zhou HH, Shay SD, Wood AJ. Contribution of differences in plasma binding of propranolol to ethnic differences in sensitivity. Comparison between Chinese and Caucasians. Chin Med J (Engl) 1993;106(12):898-902.
28. Hung YT, Cheung NT, Ip S, Fung H, Epidemiology of heart failure in Hong Kong, 1997. Hong Kong Med J 2000;6(2):159-62.
29. Sanderson JE, Chan SK, Chan WW, Hung YT, Woo KS. The aetiology of heart failure in the Chinese population of Hong Kong - a prospective study of 730 consecutive patients. Int J Cardiol 1995;51(1):29-35.
30. Cruickshank JK, Beevers DG, Osboume VL, Haynes RA, Corlett JC, Selby S. Heart attack, stroke, diabetes, and hypertension in West Indians, Asians, and whites in Birmingham, England. Br Med J 1980;281(6248):1108.
31. Zhang J, Kesteloot H. Differences in all-cause, cardiovascular and cancer mortality between Hong Kong and Singapore: role of nutrition. Eur J Epidemiol 2001;17(5):469-77.